Monahan Joseph
SEC CIK 1861790 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | CSO | 292.9K | — | $1.67M | 26 | 2021-09-01 | 2025-03-01 |
Most active insiders at ACRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Leonard Braden Michael | 10% | — | $1.36M |
| 2 | Kolbeck Roland Wilhelm | CSO | — | — |
| 3 | Hall Jesse Wayne | Chief Medical Off | — | — |
| 4 | Davis Hugh M. | Pres, COO, Dir | — | — |
| 5 | Balthaser Kevin | CFO | — | — |
| 6 | Loerop James | Chief Business Off | — | — |
| 7 | Humphries William D. | Dir | — | — |
| 8 | Molineaux Christopher P. | Dir | — | — |
| 9 | Walker Neal | CEO, Dir | — | — |
| 10 | Mehra Anand | Dir | — | — |
Monahan Joseph made no open-market trades at ACRS in the last 12 months.
Transactions 26
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-04 | 2025-03-01 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | M - OptEx | — | +60.9K | 292.9K | +26% | — |
| D | 2025-03-04 | 2025-03-01 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | F - Tax | $1.99 | -27.3K | 265.7K | -9% | -$54.2K |
| DM | 2025-02-04 | 2025-02-01 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | M - OptEx | — | +22.2K | 243.3K | +10% | — |
| D | 2025-02-04 | 2025-02-01 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | F - Tax | $2.48 | -11.3K | 232.0K | -5% | -$28.1K |
| DM | 2025-01-03 | 2024-12-31+ | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | F - Tax | — | -41.9K | 221.1K | -16% | — |
| DM | 2025-01-03 | 2024-12-31+ | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | M - OptEx | — | +91.1K | 245.5K | +59% | — |
| 2024-12-12 | 2024-12-10 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | G - Gift | $0.00 | -15.0K | 171.8K | -8% | $0 | |
| DM | 2024-03-05 | 2024-03-01+ | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | F - Tax | $1.24 | -21.3K | 186.8K | -10% | -$26.4K |
| DM | 2024-03-05 | 2024-03-01+ | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | M - OptEx | — | +73.4K | 184.6K | +66% | — |
| D | 2024-02-05 | 2024-02-01 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | F - Tax | $1.20 | -2,583 | 134.6K | -2% | -$3,100 |
| D | 2024-02-05 | 2024-02-01 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | M - OptEx | — | +7,500 | 137.2K | +6% | — |
| 2023-10-25 | 2023-10-23 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | S - Sale | $5.08 | -6,000 | 129.7K | -4% | -$30.5K | |
| 2023-08-22 | 2023-08-21 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | S - Sale | $7.32 | -6,000 | 135.7K | -4% | -$43.9K | |
| 2023-06-22 | 2023-06-20 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | S - Sale | $10.28 | -6,000 | 141.7K | -4% | -$61.7K | |
| DM | 2023-03-03 | 2023-03-01+ | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | M - OptEx | — | +87.2K | 166.1K | +111% | — |
| DM | 2023-03-03 | 2023-03-02+ | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | S - Sale+OE | $12.51 | -30.8K | 147.7K | -17% | -$385.6K |
| 2023-02-17 | 2023-02-15 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | S - Sale | $13.06 | -5,000 | 91.4K | -5% | -$65.3K | |
| 2022-12-16 | 2022-12-15 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | S - Sale | $15.88 | -5,000 | 96.4K | -5% | -$79.4K | |
| 2022-10-19 | 2022-10-17 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | S - Sale | $15.98 | -5,000 | 101.4K | -5% | -$79.9K | |
| 2022-04-20 | 2022-04-18 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | S - Sale | $16.28 | -30.0K | 106.4K | -22% | -$488.4K | |
| 2022-03-14 | 2022-03-10 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | S - Sale | $15.71 | -27.2K | 136.4K | -17% | -$426.8K | |
| DM | 2022-03-03 | 2022-03-01+ | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | M - OptEx | — | +76.2K | 151.1K | +102% | — |
| 2022-02-11 | 2022-02-09 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | S - Sale | $12.68 | -383 | 87.3K | -0.4% | -$4,856 | |
| D | 2022-02-03 | 2022-02-01 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | M - OptEx | — | +1,050 | 87.7K | +1% | — |
| D | 2021-09-02 | 2021-09-01 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | F - Tax | $17.22 | -1,041 | 86.6K | -1% | -$17.9K |
| D | 2021-09-02 | 2021-09-01 | ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | CSO | M - OptEx | — | +2,333 | 87.7K | +3% | — |
Purchase Sale Sale after option exercise All abbreviations